Drones In America: A New Podcast Exploring UAV Technology and Policy

On New Year’s Eve 2019, the Federal Aviation Administration released a Notice of Proposed Rulemaking for Remote Identification of drone users.

“It was 88,000 words of seemingly good intention, and 87 pages of common sense,” Tom Walker said. “There wasn’t any thing in there [the NPRM] that should have surprised anyone.”

Drones continue to disrupt various corners of the private sector that very few people predicted. Presenting Drones in America an all-new podcast by MarketScale centered around drones.

Every week, Drones in America will introduce listeners to guests who are leaders, influencers, and experts from various areas to talk about America’s drone industry.
Topics discussed will include the history of drones, new technology, policy, and the rapidly-growing commercial market.

Tom Walker is Founder and CEO of droneUp, a company that provided “end-to-end aerial data collection services for large, autonomous missions.” He appeared on the inaugural episode of Drones in America to talk about the FAA’s NPRM, how he got into the drone industry, and the relationship between policymakers and drone users.

“When I was first exposed to the consumer drone market… I felt like there were two key issues,” Walker said. “First, there would be a person in the unnamed space. Second, most organizations would be unable to manage the fleet of equipment and pilots.”

In short, Walker saw a need for a scalable drone platform, so he founded droneUp in 2016.
droneUp worked with local emergency response services for wildfires in the West and Hurricane response in the Southeast.

Join host Grant Guillot of the law firm, Adams and Reese for Drones in America with new episodes available where ever podcasts are found.

 

Coming Later This Spring! A New MarketScale Original Series

 

Transportation. Surveillance. Geo-Mapping. First Response. Counterterrorism. One piece of technology is powering these varied markets like no other: the drone. Drones have finally won the tool vs. toy debate in the commercial world, & now they have to prove themselves to each industry as the best solution for a diverse set of jobs. Still, questions remain. Are they safe? Are they reliable? Are they profitable?

On Beyond Line of Sight MarketScale is going around the U.S. to meet face-to-face with the innovators determined to take drones mainstream.

Delivering the Future

In Plainfield, Illinois Valqari is trying to revolutionize the “the last mile” of the supply chain. The startup is building an infrastructure across America to improve product deliveries using drones and mitigating the rising issue of package theft. Can they do it?

 

Follow us on social media for the latest updates in B2B!

Image

Latest

cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More
organoids
Growing the Future of Cancer Research: Inside the Promise of Organoids
April 19, 2025

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…

Read More
Immuno-Oncology
Shaping the Future of Cancer Care Through Immuno-Oncology
April 19, 2025

In the ever-evolving world of cancer treatment, immuno-oncology (IO) continues to stand at the forefront of innovation. With recent FDA approvals for TIL therapies and bispecific antibodies, and new developments in CAR-T technologies, the field is rapidly expanding into combination-based strategies that integrate with standard care. Researchers are also exploring how to overcome challenges posed…

Read More